Proteomics International, inVentiv Health Sign Biosimilar Agreement

News   Mar 01, 2014

 
Proteomics International, inVentiv Health Sign Biosimilar Agreement
 
 
 

RELATED ARTICLES

Barrier to Liquid Biopsies Overcome with Blood Stabilization Technique

News

A new technique that prolongs the lifespan of blood samples could be a breakthrough for liquid biopsy assays.

READ MORE

Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

News

In a new study, scientists show that a targeted drug blocking the action of a cancer-driving protein can kill testicular cancer cells and, alongside chemotherapy, could reverse drug resistance.

READ MORE

All in a Droplet: Atomic Resolution of ALS Protein Resolved

News

Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE